Galen Partners

David Jahns is a Managing Director at Galen Partners with over 25 years of experience building healthcare companies and involvement in more than 70 growth equity investments. His focus areas include technology-enabled services, medical devices, medical robotics, diagnostics, consumer-driven healthcare, telemedicine, clinical decision support, and health IT and SaaS solutions. Before joining Galen in 1993, he worked in the Corporate Finance Department at Smith Barney as a healthcare investment banker, and he holds an MBA from Northwestern's Kellogg School of Management and a BA from Colgate University.

DT Nguyen is CEO of Koan Health, where he leads strategy and strategic alliances. He previously served as president of MedAssets' revenue cycle management business, a former Galen portfolio company, and founded XactiMed, an RCM company acquired by MedAssets in 2007. Earlier in his career he held senior executive roles at IPN Network, FoxMeyer Health, and U.S. HealthData Interchange.

Michelle Hasson has more than 20 years of experience in health care spanning life sciences, providers, and payers. She co-founded medical product and business strategy consulting firm Easton Associates, which she grew and later sold to a publicly traded company, and has advised executives, investors, and boards on strategy, clinical development, and M&A. She holds a bachelor's degree from Emory and a graduate degree from Yale University's School of Medicine.

Steve Cashman previously served as Chief Commercial Officer at InTouch Health, overseeing domestic and global sales along with product, marketing, and customer service. He was the founder and CEO of telemedicine company HealthSpot, which was recognized as the Consumer Electronics Association small business of the year in 2013, and earlier held the Chief Strategy Officer role at Exceptional Innovation. His work focuses on using technology to improve the patient experience and access to healthcare.

Zubeen Shroff is a Managing Director at Galen Partners, a healthcare growth equity investment firm, which he joined in 1997. He has over 30 years of experience building healthcare companies across areas such as specialty pharmaceuticals, medical imaging, therapeutic devices, diagnostics, and technology-enabled services. Before Galen, he was a Principal at The Wilkerson Group and began his career at Schering-Plough Pharmaceuticals. He holds an M.B.A. from the Wharton School and a B.A. in Biological Science from Boston University.